Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

July 01, 2014; Volume 86,Issue 1

Accelerated Communication

  • You have access
    Discovery and Characterization of a G Protein–Biased Agonist That Inhibits β-Arrestin Recruitment to the D2 Dopamine Receptor
    R. Benjamin Free, Lani S. Chun, Amy E. Moritz, Brittney N. Miller, Trevor B. Doyle, Jennie L. Conroy, Adrian Padron, Julie A. Meade, Jingbo Xiao, Xin Hu, Andrés E. Dulcey, Yang Han, Lihua Duan, Steve Titus, Melanie Bryant-Genevier, Elena Barnaeva, Marc Ferrer, Jonathan A. Javitch, Thijs Beuming, Lei Shi, Noel T. Southall, Juan J. Marugan and David R. Sibley
    Molecular Pharmacology July 2014, 86 (1) 96-105; DOI: https://doi.org/10.1124/mol.113.090563

Articles

  • You have access
    The Physical Association of the P2Y12 Receptor with PAR4 Regulates Arrestin-Mediated Akt Activation
    Aasma Khan, Dongjun Li, Salam Ibrahim, Emer Smyth and Donna S. Woulfe
    Molecular Pharmacology July 2014, 86 (1) 1-11; DOI: https://doi.org/10.1124/mol.114.091595
  • You have access
    Antileukemic Activity and Mechanism of Drug Resistance to the Marine Salinispora tropica Proteasome Inhibitor Salinosporamide A (Marizomib)
    Denise Niewerth, Gerrit Jansen, Lesley F. V. Riethoff, Johan van Meerloo, Andrew J. Kale, Bradley S. Moore, Yehuda G. Assaraf, Janet L. Anderl, Sonja Zweegman, Gertjan J. L. Kaspers and Jacqueline Cloos
    Molecular Pharmacology July 2014, 86 (1) 12-19; DOI: https://doi.org/10.1124/mol.114.092114
  • You have access
    Mutations in the Main Cytoplasmic Loop of the GABAA Receptor α4 and δ Subunits Have Opposite Effects on Surface Expression
    John R. Bracamontes, Ping Li, Gustav Akk and Joe Henry Steinbach
    Molecular Pharmacology July 2014, 86 (1) 20-27; DOI: https://doi.org/10.1124/mol.114.092791
  • You have access
    Structure, Molecular Modeling, and Function of the Novel Potassium Channel Blocker Urotoxin Isolated from the Venom of the Australian Scorpion Urodacus yaschenkoi
    Karen Luna-Ramírez, Adam Bartok, Rita Restano-Cassulini, Veronica Quintero-Hernández, Fredy I. V. Coronas, Janni Christensen, Christine E. Wright, Gyorgy Panyi and Lourival D. Possani
    Molecular Pharmacology July 2014, 86 (1) 28-41; DOI: https://doi.org/10.1124/mol.113.090183
  • You have access
    Synergy-Based Small-Molecule Screen Using a Human Lung Epithelial Cell Line Yields ΔF508-CFTR Correctors That Augment VX-809 Maximal Efficacy
    Puay-Wah Phuan, Guido Veit, Joseph Tan, Ariel Roldan, Walter E. Finkbeiner, Gergely L. Lukacs and A. S. Verkman
    Molecular Pharmacology July 2014, 86 (1) 42-51; DOI: https://doi.org/10.1124/mol.114.092478
  • You have access
    Desensitization of Functional µ-Opioid Receptors Increases Agonist Off-Rate
    John T. Williams
    Molecular Pharmacology July 2014, 86 (1) 52-61; DOI: https://doi.org/10.1124/mol.114.092098
  • You have access
    Characterization of the Zebrafish Ugt Repertoire Reveals a New Class of Drug-Metabolizing UDP Glucuronosyltransferases
    Yuanming Wang, Haiyan Huang and Qiang Wu
    Molecular Pharmacology July 2014, 86 (1) 62-75; DOI: https://doi.org/10.1124/mol.113.091462
  • You have access
    An N-Terminal Threonine Mutation Produces an Efflux-Favorable, Sodium-Primed Conformation of the Human Dopamine Transporter
    Rheaclare Fraser, Yongyue Chen, Bipasha Guptaroy, Kathryn D. Luderman, Stephanie L. Stokes, Asim Beg, Louis J. DeFelice and Margaret E. Gnegy
    Molecular Pharmacology July 2014, 86 (1) 76-85; DOI: https://doi.org/10.1124/mol.114.091926
  • You have access
    A Plasma Concentration of α-Ketoglutarate Influences the Kinetic Interaction of Ligands with Organic Anion Transporter 1
    Leslie Ingraham, Mansong Li, J. Larry Renfro, Sonda Parker, Arpine Vapurcuyan, Imad Hanna and Ryan M. Pelis
    Molecular Pharmacology July 2014, 86 (1) 86-95; DOI: https://doi.org/10.1124/mol.114.091777
  • You have access
    Characterization of the Novel Positive Allosteric Modulator, LY2119620, at the Muscarinic M2 and M4 Receptors
    Carrie H. Croy, Douglas A. Schober, Hongling Xiao, Anne Quets, Arthur Christopoulos and Christian C. Felder
    Molecular Pharmacology July 2014, 86 (1) 106-115; DOI: https://doi.org/10.1124/mol.114.091751
  • You have access
    Development of a Radioligand, [3H]LY2119620, to Probe the Human M2 and M4 Muscarinic Receptor Allosteric Binding Sites
    Douglas A. Schober, Carrie H. Croy, Hongling Xiao, Arthur Christopoulos and Christian C. Felder
    Molecular Pharmacology July 2014, 86 (1) 116-123; DOI: https://doi.org/10.1124/mol.114.091785

Erratum

  • You have access
    Correction to “Novel and Specific Inhibitors of a Poxvirus Type I Topoisomerase”
    Molecular Pharmacology July 2014, 86 (1) 124; DOI: https://doi.org/10.1124/mol.114.07er14
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 86 (1)
Molecular Pharmacology
Vol. 86, Issue 1
1 Jul 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Accelerated Communication
  • Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics